• Je něco špatně v tomto záznamu ?

Nedilatovaná kardiomyopatie
[Prevalence and clinical characteristics of nondilated cardiomyopathy and the effect of atrial fibrillation]

Doumas A, et al.

Jazyk čeština Země Česko

Perzistentní odkaz   https://www.medvik.cz/link/bmc10027718

The treatment of patients with chronic heart failure and those with asymptomatic left ventricular (LV) dysfunction has focused primarily on patients with LV enlargement and a low ejection fraction (EF). Little attention has been paid to those with a normal chamber size and a low EF. We sought to examine the LV geometry and clinical characteristics in such patients with nondilated cardiomyopathy. Of 3,350 transthoracic echocardiograms performed during a 6-month period, 696 showed an EF of < or =0.45. The patients with an end-diastolic diameter of >56 mm, regional wall motion abnormalities, or valvular disease were excluded. Of the 696 patients, 98 met these criteria, and their medical records were reviewed. The average age was 71 +/- 14 years, and 56% were men. Common co-morbidities included hypertension in 52% and atrial fibrillation (AF) in 43%. Only 22% had disabling cardiac symptoms (functional class III or greater). The average end-diastolic dimension was 49 +/- 5 mm, and the EF was 34 +/- 8%. LV hypertrophic remodeling was present in 53%. A second echocardiogram (422 +/- 177 days after the baseline study) was available for 54 patients. The chamber size was unchanged, but the EF had increased from 33 +/- 8% to 40 +/- 14% (p <0.01). The improvement in EF was seen in the group with AF (33 +/- 6% to 44 +/- 15%, p <0.01) but not in those with normal sinus rhythm (33 +/- 9% to 37 +/- 12%, p = NS). In conclusion, 14% of patients with an EF of < or =0.45 had nondilated cardiomyopathy, often with LV hypertrophic remodeling and/or AF. An improvement in LV function can be expected in many patients with nondilated cardiomyopathy, particularly those with AF.

Prevalence and clinical characteristics of nondilated cardiomyopathy and the effect of atrial fibrillation

000      
00000naa 2200000 a 4500
001      
bmc10027718
003      
CZ-PrNML
005      
20111210192649.0
008      
101022s2010 xr e cze||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a cze $b eng
044    __
$a xr
100    1_
$a Doumas, Alexander
245    10
$a Nedilatovaná kardiomyopatie / $c Doumas A, et al.
246    11
$a Prevalence and clinical characteristics of nondilated cardiomyopathy and the effect of atrial fibrillation
314    __
$a Department of Cardiovascular Medicine, Lahey Clinic Medical Center, Burlington, Massachusetts
520    9_
$a The treatment of patients with chronic heart failure and those with asymptomatic left ventricular (LV) dysfunction has focused primarily on patients with LV enlargement and a low ejection fraction (EF). Little attention has been paid to those with a normal chamber size and a low EF. We sought to examine the LV geometry and clinical characteristics in such patients with nondilated cardiomyopathy. Of 3,350 transthoracic echocardiograms performed during a 6-month period, 696 showed an EF of < or =0.45. The patients with an end-diastolic diameter of >56 mm, regional wall motion abnormalities, or valvular disease were excluded. Of the 696 patients, 98 met these criteria, and their medical records were reviewed. The average age was 71 +/- 14 years, and 56% were men. Common co-morbidities included hypertension in 52% and atrial fibrillation (AF) in 43%. Only 22% had disabling cardiac symptoms (functional class III or greater). The average end-diastolic dimension was 49 +/- 5 mm, and the EF was 34 +/- 8%. LV hypertrophic remodeling was present in 53%. A second echocardiogram (422 +/- 177 days after the baseline study) was available for 54 patients. The chamber size was unchanged, but the EF had increased from 33 +/- 8% to 40 +/- 14% (p <0.01). The improvement in EF was seen in the group with AF (33 +/- 6% to 44 +/- 15%, p <0.01) but not in those with normal sinus rhythm (33 +/- 9% to 37 +/- 12%, p = NS). In conclusion, 14% of patients with an EF of < or =0.45 had nondilated cardiomyopathy, often with LV hypertrophic remodeling and/or AF. An improvement in LV function can be expected in many patients with nondilated cardiomyopathy, particularly those with AF.
650    _2
$a senioři $7 D000368
650    _2
$a fibrilace síní $x komplikace $x patofyziologie $x ultrasonografie $7 D001281
650    _2
$a kardiomyopatie $x komplikace $x patofyziologie $x ultrasonografie $7 D009202
650    _2
$a echokardiografie $7 D004452
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a hypertrofie levé komory srdeční $x komplikace $x patofyziologie $x ultrasonografie $7 D017379
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a tepový objem $7 D013318
650    _2
$a funkce levé komory srdeční $7 D016277
650    _2
$a remodelace komor $7 D020257
773    0_
$w MED00012706 $t Clinical cardiology alert $g Roč. 4, č. 4 (2010), s. 28 $x 1213-2586
787    18
$w bmc10027719 $i Recenze v: $t Komentář [k článku Nedilatovaná kardiomyopatie]
910    __
$a ABA008 $b B 2242 $c 407 a $y 7
990    __
$a 20101013125906 $b ABA008
991    __
$a 20110131102226 $b ABA008
999    __
$a ok $b bmc $g 802829 $s 667602
BAS    __
$a 3
BMC    __
$a 2010 $b 4 $c 4 $d 28 $m Clinical Cardiology Alert $x MED00012706
LZP    __
$a 2010-29/mkme

Najít záznam